Head to Head Survey: CareFusion (CFN) and Its Competitors

CareFusion (NYSE: CFN) is one of 82 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its competitors? We will compare CareFusion to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, earnings, profitability and valuation.

Analyst Ratings

This is a breakdown of recent recommendations for CareFusion and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareFusion 0 0 0 0 N/A
CareFusion Competitors 274 1329 2802 101 2.61

As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.54%. Given CareFusion’s competitors higher probable upside, analysts plainly believe CareFusion has less favorable growth aspects than its competitors.

Profitability

This table compares CareFusion and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CareFusion 16.18% 12.80% 7.62%
CareFusion Competitors -436.97% -31.34% -15.47%

Earnings and Valuation

This table compares CareFusion and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CareFusion N/A N/A 25.51
CareFusion Competitors $975.11 million $120.37 million 276.70

CareFusion’s competitors have higher revenue and earnings than CareFusion. CareFusion is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

65.7% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 12.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

CareFusion competitors beat CareFusion on 5 of the 8 factors compared.

About CareFusion

CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company’s primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Receive News & Ratings for CareFusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareFusion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply